Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) announced in Q3 CY2025, but sales were flat year on year at $76.32 million. On the other hand, next quarter’s revenue guidance of $73.5 ...

Healthcare software provider Health Catalyst (NASDAQ:HCAT) in Q2 CY2025, with sales up 6.3% year on year to $80.72 million. On the other hand, next quarter’s revenue guidance of $75 million was less ...

Across the recent three months, 4 analysts have shared their insights on Health Catalyst (NASDAQ:HCAT), expressing a variety of opinions spanning from bullish to bearish. The following table provides ...

Analysts' ratings for Health Catalyst HCAT over the last quarter vary from bullish to bearish, as provided by 6 analysts. The table below provides a concise overview of recent ratings by analysts, ...

SALT LAKE CITY, Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, ...

Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY, Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a ...

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Health Catalyst (NASDAQ:HCAT) in the last three months. The following table encapsulates their ...

SALT LAKE CITY , Sept. 5, 2023 /PRNewswire/ -- Health Catalyst, Inc. (HCAT) ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare ...

In the last three months, 8 analysts have published ratings on Health Catalyst (NASDAQ:HCAT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...